AQT
LIVE

Serial Number

97531662

Owner

CellMosaic, Inc.

Attorney

Yin P. Zhang

First Use Date

Sep 19, 2011

Filing Date

Aug 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AQT Trademark

Serial Number: 97531662 • Registration: 7377224

AQT is a trademark filed by CellMosaic, Inc. on August 2, 2022. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CellMosaic, Inc. (3 trademarks)

10A Roessler Road
Woburn, MA 01801

Entity Type: 03

Trademark Details

Filing Date

August 2, 2022

Registration Date

May 7, 2024

First Use Anywhere

September 19, 2011

First Use in Commerce

March 24, 2021

Published for Opposition

February 20, 2024

Goods & Services

Biochemicals for scientific research use, namely, enzymes, peptide, polypeptides, polysaccharides, carbohydrates in the nature of sugars, antibodies, fragments of antibodies, proteins, membrane proteins, nucleic acids, oligonucleotides, toxin, liposomes, reagents in the nature of probes for detecting and analyzing molecules in protein or nucleotide arrays; chemically modified biochemicals, namely, enzymes, peptide, polypeptides, antibodies, fragments of antibodies, proteins, membrane proteins, nucleic acids, oligonucleotides, toxin, liposomes, reagents in the nature of probes for detecting and analyzing molecules in protein or nucleotide arrays, each modified with one or more sugar alcohol compounds for scientific research use; chemicals for use in the purification of proteins for in vitro use; chemicals for use in the biochemical industry, namely, chemicals for use in labeling and modifying biochemicals; chemicals for use in biotechnological product development; chemicals for use in the biochemical and chemical industry; assays and reagents for research purposes, namely, assays and reagents for scientific and medical research use; diagnostic reagents for scientific or research use, not for medical use, namely, diagnostic reagents relating to biomedical applications for scientific and research use; biological tissues, namely, blood and stem cells for use in scientific research, scientific laboratory research, and medical research; diagnostic kits for scientific and research use other than for medical use, namely, diagnostic kits consisting of biochemicals, buffers, and reagents for detecting analytes of biological and chemical relevance applied to scientific and biomedical research; reagent kits comprising biochemicals, buffers, and reagents for laboratory and scientific research use; kit comprised primarily of chemicals for use in the purification and labeling of proteins for in vitro use and pre-made buffer concentrate solutions for use in analytical chemistry and also including syringes, pre-packed columns for use in purification, and a downloadable and printed instructional manual all for protein purification for in vitro use and laboratory use, namely, laboratory functional studies; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid

Laboratory research services in the field of biochemistry, specifically in the fields of synthesis and purification of biochemicals, chemical modification of biochemicals, gene and protein detection; custom design and development of chemical reagents and biochemical assays for biomedical, scientific, and technological applications; working on and evaluation of chemical syntheses

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 7, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 7, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 20, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 16, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 24, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 24, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 24, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2023 CNRT
ASSIGNED TO EXAMINER
May 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2022 NWOS
NEW APPLICATION ENTERED
Aug 5, 2022 NWAP